Infant Bacterial Therapeutics: FDA Grants Infant Bacterial Therapeutics AB's Request for a Type B Pre-BLA Meeting

Infant Bacterial Therapeutics AB (IBT) announced today that the U.S. Food and Drug Administration (FDA), has granted the company's request for a Type B Pre-BLA (Pre-Biologics License Application) m...